The ftsY primers amplified products from all 71 MRSA genotyping
strains and from the S. aureus JNBP05244T type strain. These
primers did not amplify products from any of the remaining 29 type
strains of the genus Staphylococcus described in the Materials &
Methods. The mecA primer also amplified products from all 71
MRSA genotyping strains, but not from any of the 30 Staphylococcus
genus type strains listed above. The blaZ primer also amplified
products from all 12 b-lactamase-positive S. aureus clinical isolates,
but not from any of the 12 b-lactamase-negative clinical isolates.